Announced Mon, 24 Aug · 12:51 IST

Board meeting on Aug 31 to approve 37th AGM notice and annual report

Board & Shareholder Meetings View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.0%1-day move
₹16.47
prior close
₹15.35
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-6.0-11.6-3.8-3.0-3.8-15.6-8.9
Up moveDown movePending
AI summary

Venmax Drugs and Pharmaceuticals has called a Board meeting on August 31, 2026 at 4:30 PM. Key agenda includes approving the 37th AGM notice, Directors Report and Annual Report for FY 2025-26, finalising AGM date and venue, fixing e-voting cut-off dates, and appointing the scrutinizer and e-voting agency. The Board will also consider regularising the appointment of Additional Directors and a change in designation of the Whole-time Director, subject to shareholder approval.

Likely market impact

Routine pre-AGM board meeting; AGM date and director changes will follow post-meeting. Watch for AGM date announcement.